Therapeutics - Erectile Dysfunction

  1. avanafil
    Stendra
  2. sildenafil
    Viagra
  3. tadalafil
    Cialis
  4. vardenafil
    Levitra, Staxyn
  5. intracavernisal
    Caverject, Edex
  6. intraurethral
    Muse
  7. buccal system
    Striant
  8. gel
    Androgel, Fortesta, Testim, Vogelxo
  9. injection
    Depo-testosterone, Delatestryl
  10. transdermal patch
    Androderm
  11. transdermal solution
    Axiron
  12. Name all 4 PDE Inhibitors
    • 1. avanafil - Stendra
    • 2. sildenafil - Viagra
    • 3. tadalafil - Cialis
    • 4. vardenafil - Levitra, Staxyn
  13. Name 2 PGE1's (Alprostadil)
    • 1. intracavernosal - Caverject, Edex
    • 2. intraurethral - Muse
  14. Name 5 Testosterone
    • 1. buccal system - Striant
    • 2. gel - Androgel, Fortesta, Testim, Vogelxo
    • 3. injection - Depo-testosterone, Delatestry
    • 4. transdermal patch - Androderm
    • 5. transdermal solution - Axiron
  15. What are potentially correctible co-morbid conditions of erectile dysfunction?
    • 1. Diabetes
    • 2. Tobacco Use
    • 3. Alcohol Use
  16. What medications may be potentially correctable causes of erectile dysfunction? (there are 7 classes)
    • 1. Anticholinergics
    • 2. anti-androgen drugs
    • 3. CNS depressants
    • 4. antidepressants
    • 5. diuretics
    • 6. beta-blockers
    • 7. 5alpha reductase inhibitors
  17. How does PDE1 (prostaglandin-1; Alprostadil) work in erectile dysfunction?
    PDE (prostaglandin-1; Alprostadil) works as a vasodilator. Muse is a penile suppository that is inserted into the urethra, while Caverject and Edex are injected by syringe directly into the corpus cavernosum. This opens blood vessels by relaxing smooth muscle.
  18. Which PGE1 is more effective?
    Intracavernosal (Caverject, Edex)
  19. What medication group of "non-responders" does PGE-1 have a HIGH response in?
    PDE-5 (Phosphodiesterase-5 inhibitors)
  20. What population of patients have a lower response to PDE5 inhibitors?
    • 1. diabetics
    • 2. those w/ vascular disease
  21. How are patients on PDE5 inhibitors who are categorized as "non-responders" assessed?
    • 1. adherence
    • 2. if doses have been correctly titrated
    • 3. if at least 7-8 doses have been given for prn drugs; if daily, should be on it for a month
  22. Class of erectile dysfunction (ED) medication that has a a response in patients regardless of ED etiology, including "low T".
    PDE-5 inhibitors
  23. What is the only PDE-5 inhibitor that can be used under ANY hepatic condition?
    Sildenafil (Viagra)
  24. Which PDE-5 inhibitors are prohibited from use when a patient is on dialysis?
    Vardenafil (Levitra) and Vardenafil ODT (Staxyn)
  25. List STRONG CYP inhibitors of PDE-5 inhibitors.
    • CYPE3A4
    • atazanavir, clarithromycin, indanavir, itraconazole, ketoconazole, nefazodone, nelfinavir, saquinavir, ritonavir, and telithromycin
  26. List MODERATE inhibitors of PDE-5 inhibitors
    • CYP3A4
    • amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, verapamil
  27. What are the dose related side effects of PDE-5 inhibitors?
    • 1. headache
    • 2. facial flushing
    • 3. dyspepsia
    • 4. dizziness
    • 5. visual changes (not seen in tadalafil)
    • 6. lower back and limb muscle pain (tadalafil only)
  28. What are special considerations when using tadalafil (Cialis) not seen with other PDE-5 inhibiotrs?
    • 1. Will NOT have "visual changes" as with others in its class
    • 2. Will NOT decreae blood pressure by 8-10mmHG/5-6 mmHG like other PDE-5 inhibitors
    • 3. The ONLY PDE-5 inhibitor to cause lower back and limb muscle pain
  29. What class of medications used in erectile dysfunction should be reviewed for STOPP criteria in people over the age of 65? What condition and monitoring parameter should these meds be avoided?
    • 1. PDE-5 inhibitors
    • 2. Severe heart failure when SBP <90 mmHg
  30. What is the safety profile for testosterone?
    • 1. Sodium and fluid retention
    • 2. increased Hct
    • 3. Gynecomastia
    • 4. Class III - potential for abuse
    • 5. Cardiovascular (heart attack/stroke) NNH-71
  31. Which formulation of testosterone alters mood and/or libido?
    Injection
  32. Which formulation(s) of testosterone poses the possibility for transfer from person to person?
    • 1. Solution
    • 2. Gel
  33. What monitoring parameters are important to watch for with testosterone use and why?
    • 1. Hct - if >54% stop therapy
    • 2. PSA - if >4ng/L or an increase by 1.4ng/L
    • 3. LFT's
Author
mbailey585
ID
328871
Card Set
Therapeutics - Erectile Dysfunction
Description
Erectile Dysfunction
Updated